These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22056948)

  • 21. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
    Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinico-epidemiological study of endometrial hyperplasia--a risk factor for the development of endometrial carcinoma?
    Cărăuleanu A; Lupaşcu IA; Cărăuleanu DM; Socolov R; Socolov D
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):154-61. PubMed ID: 25970959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of additional pathology comments indicating suspicion of adenocarcinoma among women diagnosed preoperatively with complex atypical endometrial hyperplasia.
    Suh-Burgmann E; Hung YY; Armstrong MA
    Int J Gynecol Pathol; 2012 May; 31(3):222-6. PubMed ID: 22498938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma with a background of complex atypical hyperplasia and final hysterectomy pathology.
    Leitao MM; Kehoe S; Barakat RR; Alektiar K; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
    Am J Obstet Gynecol; 2010 Mar; 202(3):278.e1-6. PubMed ID: 20022581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial hyperplasia and the risk of endometrial carcinoma.
    Ho SP; Tan KT; Pang MW; Ho TH
    Singapore Med J; 1997 Jan; 38(1):11-5. PubMed ID: 9269346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complex hyperplasia of the endometrium. Predictive value of curettage vs. hysterectomy specimens.
    Lambert B; Muteganya D; Lepage Y; Boivin Y
    J Reprod Med; 1994 Aug; 39(8):639-42. PubMed ID: 7996530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of curettage in diagnosis of endometrial hyperplasia.
    Xie X; Lu WG; Ye DF; Chen HZ; Fu YF
    Gynecol Oncol; 2002 Jan; 84(1):135-9. PubMed ID: 11748989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-operative frozen section results reliably predict final pathology in endometrial cancer.
    Stephan JM; Hansen J; Samuelson M; McDonald M; Chin Y; Bender D; Reyes HD; Button A; Goodheart MJ
    Gynecol Oncol; 2014 Jun; 133(3):499-505. PubMed ID: 24699308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk and predictors of malignancy in women with endometrial polyps.
    Wethington SL; Herzog TJ; Burke WM; Sun X; Lerner JP; Lewin SN; Wright JD
    Ann Surg Oncol; 2011 Dec; 18(13):3819-23. PubMed ID: 21701931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
    Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
    Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrial atypical hyperplasia and subsequent diagnosis of endometrial cancer: a retrospective audit and literature review.
    Pennant S; Manek S; Kehoe S
    J Obstet Gynaecol; 2008 Aug; 28(6):632-3. PubMed ID: 19003662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of final histology in patients with endometrial cancer.
    Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
    Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study.
    Kipp BR; Medeiros F; Campion MB; Distad TJ; Peterson LM; Keeney GL; Halling KC; Clayton AC
    Cancer; 2008 Aug; 114(4):228-35. PubMed ID: 18548528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of MRI in management of endometrial hyperplasia with atypia.
    Natarajan P; Vinturache A; Hutson R; Nugent D; Broadhead T
    World J Surg Oncol; 2020 Feb; 18(1):34. PubMed ID: 32041614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complex non atypical hyperplasia and the subsequent risk of carcinoma, atypia and hysterectomy during the following 9-14 years.
    Iversen ML; Dueholm M
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():171-175. PubMed ID: 29413816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage.
    Suh-Burgmann E; Hung YY; Armstrong MA
    Obstet Gynecol; 2009 Sep; 114(3):523-529. PubMed ID: 19701030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia.
    Shutter J; Wright TC
    Int J Gynecol Pathol; 2005 Oct; 24(4):313-8. PubMed ID: 16175074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of benign endometrial cells in Pap smears from postmenopausal women.
    Wu HH; Schuetz MJ; Cramer H
    J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
    Ivanov S
    Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.